Skip redundant pieces
Department of Pediatrics
Pediatrics Home  :  About KU Pediatrics  :  Faculty  

Jennifer Lowry, M.D.

Some of the patients seen by KU Pediatrics.

Clinical Interests:

  • Pediatric Enviromental Health
  • Envenomations including Brown Recluse Spiders
  • Adolescent Substance Abuse
  • The poisoned patient

Research Interests:

  • Heavy metals in children
  • Developmental Pharmacology

 

Related Info

List of Faculty

Faculty by Division

Pediatric Divisions

Specialty:
 Toxicology
Position:
 Clinical Assistant Professor
E-Mail:
 jlowry@kumc.edu
Telephone:
 913-588-7109
Facsimile:
 913-588-2350
Office Location:
 B400 KU Hospital
Mailing Address:
 Mail Stop 4040
3901 Rainbow Blvd
Kansas City, KS  66160

Education & Training:

  • Undergraduate: BS (Biology): University of Wisconcin, Milwaukee, WI
  • Postgraduate: M.D. University of South Dakota, SOM
  • Residency: Pediatrics, Children's Mercy Hospital, Kansas City, MO
  • Fellowship: Clinical Pharmacology/Medical Toxicology, Children's Mercy Hospital, Kansas City, MO

 

Licensure and Certification :

  • American Board of Pediatrics
  • Licensed in the State of Missouri and Kansas

 

Professional Societies:

  • American Association of Pediatrics
  • American Association of Poison Control Centers
  • American College of Medical Toxicology
  • American Academy of Clinical Toxicology
  • American Society of Clinical Pharmacology and Therapeutics

Awards:

  • Mentored Specialized Clinical Investigator Development Award, NICHD

 

Publications:

  • Lowry JA, Vandover JC, DeGreef J, Scalzo AJ.  "Unusual Presentation of Iatrogenic Phenytoin Toxicity in a Newborn" Journal of Medical Toxicology.  2006; 1(1)

  • Lowry JA,  Kearns GL, Khan IS, Kashuba ADM, Bertino JS, Nafziger AN, Abdel-Rahman AM, Leeder JS.  Cisapride (CIS):  A Potential Model Substrate to Assess CYP3A4 Activity.  Clinical Pharmacology and Therapeutics 2003; 73: 209-222

  • Lowry JA, Jarrett RV, Wasserman G, Pettett G, Kauffman RE.  "Theophylline Toxicokinetics in Premature Newborns"  Archives of Pediatrics and Adolescent Medicine 2001; 155: 934-939

  • Lowry, JA, Corry A, Fitzmaurice L, Jackson MA, Kearns GL.  "Co-Administration of Mefloquine and Chloroquine: Use of a Pharmacokinetic-Based Approach to Reduce the Risk of Additive Toxicity" The Pediatric Infectious Diseases Journal.  2001; 20: 223-4

 

Current and Recent Grant Funding:

  • Jennifer Lowry, M.D., Principal Investigator, "Poison Control Stabilization and Enhancement Program "HRSA, Total Direct Costs: $153,636, 2005 to present.
  • Jennifer Lowry, M.D., Investigator, "Effect of Schoolyard Exposure to Diesel School Bus Emissions on Pediatric Respiratory Health", CMN, Total Direct Costs: $10,000, 2005 to present .
  • Jennifer Lowry, M.D., Principal Investigator, RADARS" Denver Health, Total Direct Costs: $13,750/a year, 2005 to present.
  • Jennifer Lowry, M.D., Principal Investigator, "Retrospective Evaluation of Venom  Effect Recurrences following Antivenom Therapy for Crotaline Snakebite" Denver Health, Total Direct Costs: $5,000, 2005.
  • Jennifer Lowry, M.D., Principal Investigator, " Cyanide Antidote Survey Study", Denver Health, Total Direct Costs: $180, 2005.
  • Jennifer Lowry, M.D., Co-Principal Investigator, " Development of a Pediatric Environmental Health Specialty Unit at the University of Kansas Medical Center", AOEC, Total Direct Costs: $111,215, 2004 to present.
  • Jennifer Lowry, M.D., Principal Investigator, " Bioterrorism Contract" KDHE, Total Direct Costs: $50,000/a year, 2004 to present.
  • Jennifer Lowry, M.D., Principal Investigator, " Lead and Its Effect on Cytochrome P450", Hall Family Foundation, Total Direct Costs: $100,000, 2001-2005.

 

top of page